Annals of Hepatology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2024-06-14 树萱来自福建省

从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏

114 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2019-04-08 Trr

请问谁成功投稿过吗？Accept已经3个月，没有音讯》

259 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2023-12-16 ms1000000012388850 来自北京

审稿速度:2.0 | 投稿命中率:95.0
经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步

111 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2023-03-26 ms8000000371219882 来自江西省

偏重的研究方向：肝片吸虫病
经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦

122 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2024-09-03 ms8000001879449519 来自浙江省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：酒精性肝病
经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应

61 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2023-06-11 ms5000001849386227 来自河南省

审稿速度:2.0 | 投稿命中率:75.0
经验分享：提交后两个月左右让大修，2周内提交，2周后接收。

136 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2022-09-03 xuanzixue02

修回后，一直under review，这个状态一般持续多久啊？

125 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2023-03-01 ms1000001332961664 来自辽宁省

偏重的研究方向：肝硬化;肝纤维化
经验分享：manuscript submitted有半个月了，正常不？

125 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2024-01-18 国统乃我辈之愿来自海南省

为啥投了10天了，还是submit，没有稿号。

102 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209871, encodeId=f9bc22098e1de, content=从接收到见刊，一般多久？有过来人分享下经验吗，十分感谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170124/IMG5886770C0FE136482.jpg, createdBy=dec42013784, createdName=树萱, createdTime=Fri Jun 14 12:10:19 CST 2024, time=2024-06-14, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=569254, encodeId=5e7456925441, content=请问谁成功投稿过吗？Accept已经3个月，没有音讯》, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Mon Apr 08 16:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223904, encodeId=14182223904a1, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：酒精性肝病 经验分享：审稿2个月，返修2周，4周录用，录用后1个多月还没有回应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fe35699357, createdName=ms8000001879449519, createdTime=Tue Sep 03 20:27:45 CST 2024, time=2024-09-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2022-08-28 Doctor小雷

偏重的研究方向：肝癌
经验分享：试一下这个OA期刊把

122 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务